Dementia
References
Citations
Beers MH, et al., eds. (2004). Merck Manual of Health and Aging. Whitehouse Station, NJ: Merck Research Laboratories.
Drugs for cognitive loss and dementia (2007). Treatment Guidelines From The Medical Letter, 5(54): 9–14.
Verghese J, et al. (2003). Low blood pressure and the risk of dementia in very old individuals. Neurology, 61(12): 1667–1672.
Garcia A, Zanibbi K (2004). Homocysteine and cognitive function in elderly people. Canadian Medical Association Journal, 171(8): 897–904.
Shumaker SA, et al. (2003). Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women. The Women's Health Initiative memory study: A randomized controlled trial. JAMA, 289(20): 2651–2662.
Espeland MA, et al. (2004). Conjugated equine estrogens and global cognitive function in postmenopausal women: Women's Health Initiative Memory Study. JAMA, 291(24): 2959–2968.
North American Menopause Society (2004). Abridged recommendations for estrogen and progestogen use in peri- and postmenopausal women: October 2004 position statement of the North American Menopause Society. Menopause Management, 13(6): 12–19. Also available online: http://www.menopausemgmt.com/issues/13-06/issue.html.
Mathuranath PS, et al. (2000). A brief cognitive test battery to differentiate Alzheimer's disease and frontotemporal dementia. Neurology, 55(11): 1613–1620.
Knopman DS, et al. (2001). Practice parameter: Diagnosis of dementia (an evidence-based review). Neurology, 56(9): 1143–1153.
Wilkinson D, et al. (2003). Donepezil in vascular dementia. Neurology, 61(4): 479–486.
Malouf R, Birks J (2006). Donepezil for vascular cognitive impairment. Cochrane Database of Systematic Reviews (4). Oxford: Update Software.
Warner J, et al. (2006). Dementia, search date February 2006. Online version of Clinical Evidence (15): 1–24.
McShane R, et al. (2006). Memantine for dementia. Cochrane Database of Systematic Reviews (4). Oxford: Update Software.
Bird TD, Miller BL (2005). Alzheimer's disease and other dementias. Harrison's Principles of Internal Medicine, 16th ed., pp. 2393–2406. New York: McGraw-Hill.
U.S. Food and Drug Administration (2005). FDA issues public health advisory for antipsychotic drugs used for treatment of behavioral disorders in elderly patients. FDA Talk Paper T05-13. Available online: http://www.fda.gov/bbs/topics/ANSWERS/2005/ANS01350.html.
Wang PS, et al. (2005). Risk of death in elderly users of conventional vs. atypical antipsychotic medications. NEJM, 353(22): 2335–2341.
Roman GC (2002). Vascular dementia revisited: Diagnosis, pathogenesis, treatment, and prevention. Medical Clinics of North America, 86(3): 477–499.
Verghese J, et al. (2003). Leisure activities and the risk of dementia in the elderly. New England Journal of Medicine, 348(25): 2508–2516.
Mukamal KJ, et al. (2003). Prospective study of alcohol consumption and risk of dementia in older adults. JAMA, 289(11): 1405–1413.
Ruitenberg A, et al. (2002). Alcohol consumption and risk of dementia: The Rotterdam study. Lancet, 359(9303): 281–286.
Jick H, et al. (2000). Statins and the risk of dementia. Lancet, 356(9242): 1627–1631.
Zandi PP, et al. (2005). Do statins reduce risk of incident dementia and Alzheimer disease? The Cache County study. Archives of General Psychiatry, 62(2): 217–224.
Li G, et al. (2004). Statin therapy and risk of dementia in the elderly. Neurology, 63(9): 1624–1628.
Tzourio C, et al. (2003). Effects of blood pressure lowering with perindopril and indapamide therapy on dementia and cognitive decline in patients with cerebrovascular disease. Archives of Internal Medicine, 163(9): 1069–1075.
Kales HC, et al. (2007). Mortality risk in patients with dementia treated with antipsychotics versus other psychiatric medications. American Journal of Psychiatry, 164(10): 1568–1576.
Richards JB, et al. (2007). Effect of selective serotonin reuptake inhibitors on the risk of fracture. Archives of Internal Medicine, 167(2): 188–194.
Spector A, et al. (2003). Efficacy of an evidence-based cognitive stimulation therapy programme for people with dementia. British Journal of Psychiatry, 183: 248–254.
Graff MJ, et al. (2006). Community-based occupational therapy for patients with dementia and their caregivers: Randomised controlled trial. BMJ, 333(1196). Also available online: http://www.bmj.com/cgi/content/full/333/7580/1196.
Other Works Consulted
Kennedy GJ (2003). Dementia. In CK Cassel et al., eds., Geriatric Medicine, 4th ed., pp. 1079–1093. New York: Springer-Verlag.
Kertesz A, Munoz DG (2002). Frontotemporal dementia. Medical Clinics of North America, 86(3): 501–518.
Knopman DS (2006). Alzheimer disease and other major dementing illnesses. In DC Dale, DD Federman, eds., ACP Medicine, section 11, chap. 11. New York: WebMD.
Knopman DS, et al. (2003). Symposium on geriatrics: Essentials of the proper diagnoses of mild cognitive impairment, dementia, and major subtypes of dementia. Mayo Clinic Proceedings, 78(10): 1290–1308.
Langa KM, et al. (2004). Mixed dementia: Emerging concepts and therapeutic implications. JAMA, 292(23): 2901–2908.
Leverenz JB, McKeith IG (2002). Dementia with Lewy bodies. Medical Clinics of North America, 86(3): 519–535.
Santacruz KS, Swagerty D (2001). Early diagnosis of dementia. American Family Physician, 63(4): 703–713.
U.S. Preventive Services Task Force (2003). Screening for dementia: Recommendation and rationale. Annals of Internal Medicine, 139(11): 925–926.
Weiner MF, Lipton AM, eds. (2003). The Dementias: Diagnosis, Treatment, and Research, 3rd ed. Washington, DC: American Psychiatric Publishing.
 Go to previous section |  Go to top of page |  Go to next section |
| Author: | Jeannette Curtis | Last Updated: June 27, 2007 |
| Medical Review: | Martin Gabica, MD - Family Medicine Peter J. Whitehouse, MD - Neurology | |
 | ||
